284 related articles for article (PubMed ID: 20146326)
1. Safety of drug eluting stents in patients on chronic anticoagulation using long-term single antiplatelet treatment with clopidogrel.
Pasceri V; Patti G; Pristipino C; Pelliccia F; Irini D; Varveri A; Roncella A; Di Sciascio G; Speciale G
Catheter Cardiovasc Interv; 2010 May; 75(6):936-42. PubMed ID: 20146326
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of modified dual antiplatelet therapy combined with warfarin following percutaneous coronary intervention with drug-eluting stents.
Baber U; Akhter M; Kothari S; Sharma SK; Kini A
J Invasive Cardiol; 2010 Feb; 22(2):80-3. PubMed ID: 20124594
[TBL] [Abstract][Full Text] [Related]
3. Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation.
Sarafoff N; Ndrepepa G; Mehilli J; Dörrler K; Schulz S; Iijima R; Byrne R; Schömig A; Kastrati A
J Intern Med; 2008 Nov; 264(5):472-80. PubMed ID: 18624903
[TBL] [Abstract][Full Text] [Related]
4. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
Marzocchi A; Saia F; Piovaccari G; Manari A; Aurier E; Benassi A; Cremonesi A; Percoco G; Varani E; Magnavacchi P; Guastaroba P; Grilli R; Maresta A
Circulation; 2007 Jun; 115(25):3181-8. PubMed ID: 17562952
[TBL] [Abstract][Full Text] [Related]
5. [Optimal platelet inhibition after coronary stent implantation. Current status].
Silber S; Hoffmeister HM; Bode C
Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions.
Brar SS; Kim J; Brar SK; Zadegan R; Ree M; Liu IL; Mansukhani P; Aharonian V; Hyett R; Shen AY
J Am Coll Cardiol; 2008 Jun; 51(23):2220-7. PubMed ID: 18534267
[TBL] [Abstract][Full Text] [Related]
7. High residual platelet reactivity after clopidogrel loading and long-term clinical outcome after drug-eluting stenting for unprotected left main coronary disease.
Migliorini A; Valenti R; Marcucci R; Parodi G; Giuliani G; Buonamici P; Cerisano G; Carrabba N; Gensini GF; Abbate R; Antoniucci D
Circulation; 2009 Dec; 120(22):2214-21. PubMed ID: 19917884
[TBL] [Abstract][Full Text] [Related]
8. A high maintenance dose of clopidogrel improves short-term clinical outcomes in patients with acute coronary syndrome undergoing drug-eluting stent implantation.
Han YL; Wang B; Li Y; Xu K; Wang SL; Jing QM; Wang ZL; Wang DM; Ma YY; Wang G
Chin Med J (Engl); 2009 Apr; 122(7):793-7. PubMed ID: 19493391
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation.
Ruiz-Nodar JM; Marín F; Sánchez-Payá J; Hurtado JA; Valencia-Martín J; Manzano-Fernández S; Roldán V; Pérez-Andreu V; Sogorb F; Valdés M; Lip GY
Eur Heart J; 2009 Apr; 30(8):932-9. PubMed ID: 19246502
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience.
Maegdefessel L; Schlitt A; Faerber J; Bond SP; Messow CM; Buerke M; Raaz U; Werdan K; Muenzel T; Weiss C
Med Klin (Munich); 2008 Sep; 103(9):628-32. PubMed ID: 18813885
[TBL] [Abstract][Full Text] [Related]
11. Design and rationale of the WOEST trial: What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing (WOEST).
Dewilde W; Berg JT
Am Heart J; 2009 Nov; 158(5):713-8. PubMed ID: 19853687
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation.
Musumeci G; Rossini R; Lettieri C; Capodanno D; Romano M; Rosiello R; Guagliumi G; Valsecchi O; Gavazzi A; Angiolillo DJ
Catheter Cardiovasc Interv; 2012 Sep; 80(3):395-405. PubMed ID: 22109961
[TBL] [Abstract][Full Text] [Related]
13. Reasonable duration of Clopidogrel use after drug-eluting stent implantation in Korean patients.
Shin DH; Chae IH; Youn TJ; Cho SI; Kwon DA; Suh JW; Chang HJ; Cho YS; Chung WY; Choi YJ; Gwon HC; Han KR; Choi DJ
Am J Cardiol; 2009 Dec; 104(12):1668-73. PubMed ID: 19962472
[TBL] [Abstract][Full Text] [Related]
14. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
Wang ZJ; Zhou YJ; Liu YY; Yu M; Shi DM; Zhao YX; Guo YH; Cheng WJ; Jia de A; Cao Z; Nie B; Ge HL; Yang SW; Yan ZX
Thromb Res; 2009 May; 124(1):46-51. PubMed ID: 19041120
[TBL] [Abstract][Full Text] [Related]
15. Prolonged clopidogrel use after bare metal and drug-eluting stent placement: the Veterans Administration drug-eluting stent study.
Faxon DP; Lawler E; Young M; Gaziano M; Kinlay S
Circ Cardiovasc Interv; 2012 Jun; 5(3):372-80. PubMed ID: 22668555
[TBL] [Abstract][Full Text] [Related]
16. Long term results of unprotected left main percutaneous coronary intervention with DES versus BMS.
Capodanno D; Di Salvo ME; Capranzano P; Seminara D; Caggegi A; Barrano G; Tamburino C
Minerva Cardioangiol; 2009 Feb; 57(1):1-6. PubMed ID: 19202514
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
Rossini R; Musumeci G; Lettieri C; Molfese M; Mihalcsik L; Mantovani P; Sirbu V; Bass TA; Della Rovere F; Gavazzi A; Angiolillo DJ
Am J Cardiol; 2008 Dec; 102(12):1618-23. PubMed ID: 19064015
[TBL] [Abstract][Full Text] [Related]
18. Observance of antiplatelet therapy after stent implantation in patients under chronic oral anticoagulant treatment.
Valencia J; Mainar V; Bordes P; Pineda J; Gómez S; Sogorb F
J Interv Cardiol; 2008 Jun; 21(3):218-24. PubMed ID: 18422520
[TBL] [Abstract][Full Text] [Related]
19. The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents.
Butler MJ; Eccleston D; Clark DJ; Ajani AE; Andrianopoulos N; Brennan A; New G; Black A; Szto G; Reid CM; Yan BP; Shaw JA; Dart AM; Duffy SJ;
Am Heart J; 2009 May; 157(5):899-907. PubMed ID: 19376319
[TBL] [Abstract][Full Text] [Related]
20. Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry.
Yan BP; Ajani AE; New G; Duffy SJ; Farouque O; Shaw J; Sebastian M; Lew R; Brennan A; Andrianopoulos N; Reid C; Clark DJ;
Int J Cardiol; 2008 Nov; 130(3):374-9. PubMed ID: 18706719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]